Light Therapy For Brain Issues In Warsaw IN (Transcranial Photobiomodulation Therapy)

“Photobiomodulation from an intranasal device resulted in improvements in the majority of parkinsonian signs (~90%) after treatment for thirty minutes per day for ten days” “Indeed, the treatment is safe to use, with no side effects and there are early and encouraging indications of photobiomodulation-induced improvements in a number of patients.”

Hamilton C, Hamilton D, Nicklason F, El Massri N, Mitrofanis J. Exploring the use of transcranial photobiomodulation in Parkinson's disease patients. Neural Regen Res. 2018 Oct;13(10):1738-1740. doi: 10.4103/1673-5374.238613. PMID: 30136687; PMCID: PMC6128061.

In regards to Parkinson’s Disease: “Of the completers, there was a significant improvement in the UPDRS-motor scale in those who switched to active treatment.”

A Double-Blind, Sham Controlled Study of Transcranial Photobiomodulation (PBM) in Parkinsons Disease (P1-11.001). Ann Liebert, Geoffrey Herkes, Claire McGee, Brian Bicknell, Hosen Kiat, Craig McLachlan; Neurology Apr 2023, 100 (17 Supplement 2) 3665

“It was found that tPBM was safe, well tolerated and improved specific motor symptoms for a majority of the sub-scores of the treatment cohort.”

McGee, C.; Liebert, A.; Bicknell, B.; Pang, V.; Isaac, V.; McLachlan, C.S.; Kiat, H.; Herkes, G. A Randomized Placebo-Controlled Study of a Transcranial Photobiomodulation Helmet in Parkinson’s Disease: Post-Hoc Analysis of Motor Outcomes. J. Clin. Med. 2023, 12, 2846.

“Measures of mobility, cognition, dynamic balance and fine motor skill were significantly improved (p < 0.05) with PBM treatment for 12 weeks and up to one year. Many individual improvements were above the minimal clinically important difference, the threshold judged to be meaningful for participants. Individual improvements varied but many continued for up to one year with sustained home treatment. There was a demonstrable Hawthorne Effect that was below the treatment effect. No side effects of the treatment were observed.”

Liebert A, Bicknell B, Laakso EL, Heller G, Jalilitabaei P, Tilley S, Mitrofanis J, Kiat H. Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study. BMC Neurol. 2021 Jul 2;21(1):256.

“NIr therapy has the potential to develop into a safe and effective neuroprotective treatment for patients with Alzheimer's and Parkinson's disease (and presumably other neurodegenerative diseases such multiple sclerosis and amyotrophic lateral sclerosis). If NIr was applied at early stages of the disease process, for example at first diagnosis, it could potentially slow further progression by protecting neurons from death. Consequently, over time, the greater neuronal survival would lessen the clinical signs and symptoms. Further, NIr therapy—because of its lack of side-effects and neuroprotective potential—is amenable to use in conjunction with other treatments. For example, patients may have NIr therapy with a reduced dosage of drugs as a first line treatment; the potential neuroprotective effect of NIr could prolong the efficacy of the drug therapy”

Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease. Frontiers in Neuroscience

[In regards to post concussion syndrome] “All patients improved clinically after PBMT and their Post injury 2 ImPACT® test results were significantly better compared to their Post injury 1 ImPACT® test results.”

Ronaldo Santiago, Jak Ozsarfati, Holly Shulman, Reuben Valenzuela, Michael Zitney. ImPACT® Assessment of Photobiomodulation Therapy for Post-Concussion Syndrome. Journal of Spine Research and Surgery 4 (2022): 001-017.